SCHEMBL5515971

SCHEMBL5515971

CCCCn1c(C)c(C)cc(C(=O)N[C@H](C(=O)O)C(C)C)c1=O

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 17/20 0.59
CNR1 P21554 5/20 0.59
PPARG P37231 2/20 0.41
PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5524174 1.00 CNR2 (0.59) CNR2CNR1PPARGPPARA
SCHEMBL5516035 0.95 CNR2 (0.54) CNR2CNR1PPARGPPARA
SCHEMBL5520492 0.91 CNR2 (0.57) CNR2CNR1
SCHEMBL27680138 0.90 CNR2 (0.58) CNR2CNR1
SCHEMBL5518058 0.89 CNR2 (0.61) CNR2CNR1PPARGPPARA
SCHEMBL14865396 0.89 CNR2 (0.61) CNR2CNR1PPARGPPARA
SCHEMBL2747807 0.89 CNR2 (0.54) CNR2CNR1
SCHEMBL5524439 0.88 CNR2 (0.61) CNR2CNR1
SCHEMBL14865386 0.88 CNR2 (0.52) CNR2CNR1PPARGPPARA
SCHEMBL5520598 0.87 CNR2 (0.46) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8367666-B2 3-carbamoyl-2-pyridone derivatives SHIONOGI & CO., LTD. (JP) 2013-02-05 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed
US-8178681-B2 methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency SHIONOGI & CO., LTD. (JP) 2012-05-15 US disclosed